Concentra Group Holdings Parent, Inc. (CON)
(Real Time Quote from BATS)
$23.74 USD
+0.59 (2.55%)
Updated Aug 29, 2024 03:20 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Concentra Group Holdings Parent, Inc. (CON) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$29.79 | $33.00 | $27.00 | 28.68% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Concentra Group Holdings Parent, Inc. comes to $29.79. The forecasts range from a low of $27.00 to a high of $33.00. The average price target represents an increase of 28.68% from the last closing price of $23.15.
Analyst Price Targets (7 )
Broker Rating
Concentra Group Holdings Parent, Inc. currently has an average brokerage recommendation (ABR) of 1.38 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to no recommendation a month ago.
Of the eight recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 75% and 12.5% of all recommendations. There was no Strong Buy or Buy recommendation a month ago.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | NA | NA | NA |
Buy | 1 | 1 | NA | NA | NA |
Hold | 1 | 0 | NA | NA | NA |
Sell | 0 | 0 | NA | NA | NA |
Strong Sell | 0 | 0 | NA | NA | NA |
ABR | 1.38 | 1.14 | NA | NA | NA |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/19/2024 | Goldman Sachs | Jamie Perse | Not Available | Strong Buy |
8/19/2024 | Not Identified | Not Identified | Not Available | Moderate Buy |
8/19/2024 | Truist Securities | David S Macdonald | Not Available | Strong Buy |
8/19/2024 | Wells Fargo Securities | Stephen Baxter | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.38 |
ABR (Last week) | 1.14 |
# of Recs in ABR | 8 |
Average Target Price | $29.79 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 168 of 253 |
Current Quarter EPS Est: | 0.36 |